<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-biomolecules-11-00624">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cummings</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Decourt</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Leverenz</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Sabbagh</surname>
    <given-names>M.N.</given-names>
   </name>
  </person-group>
  <article-title>Clinical drug development for dementia with Lewy bodies: Past and present</article-title>
  <source>Expert Opin. Investig. Drugs</source>
  <year>2019</year>
  <volume>28</volume>
  <fpage>951</fpage>
  <lpage>965</lpage>
  <pub-id pub-id-type="doi">10.1080/13543784.2019.1681398</pub-id>
  <?supplied-pmid 31614096?>
  <pub-id pub-id-type="pmid">31614096</pub-id>
 </element-citation>
</ref>
